The Middle East and Africa Omega 3 Market is predicted to grow at a CAGR of 11.3% from 2024 to 2029 and the market size is expected to be valued at USD 0.54 billion by 2029 from USD 0.32 billion in 2024.
Since omega-3 has become increasingly popular in other applications, several works is underway to determine the effects of omega-3 on the health of babies and children. It was found to be related to positive cognitive results in childhood intake of DHA-rich formula in infantile years. For boys, the bulk of brain development takes place during gestation and the first two years of life.
Babies need DHA and ARA during this time. Such nutrients are largely responsible for brain development, which is the main reason why omega-3 infant food products are being increased. As the number of workers in a household, including women, rises, parents find it difficult to track their children's health continuously. This has turned your attention to synthesis. The industry is driven by the increasing penetration of omega3 in the API market. This is in response to increased understanding of health care and chronic diseases, expanded scope of drug use and legislation that promote the use of drugs in formulations for children.
The major key players in the Middle East and Africa Omega 3 market are Aker BioMarine, GC Rieber Oils AS, Lonza, Axellus, BASF SE, DSM, Omega Protein Corporation, Luhua Biomarine (Shandong) Co., Ltd., Croda International Plc, FMC Corporation, and others.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region